Apr 06, 2020
HEMA Biologics(TM) Announces FDA Approval of SEVENFACT® [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors
Apr 01, 2020
Global Activin Receptor Type 1 Pipeline & Therapeutic Landscape Assessment, 2020
Apr 01, 2020
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors
Mar 20, 2020
CLPS Incorporation's Growth Strategies Unaffected by COVID-19; Remains Prepared for Growing Demand for Its Services
Mar 05, 2020
Amyloidosis Patient Registry Hits 300 Participants and is Now Available to Entire Community
Feb 27, 2020
BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG's Interrogative Biology® Platform
Feb 26, 2020
Hemophilia A - Forecasts for Seven Major Markets Covering the United States, EU5 and Japan
Feb 20, 2020
PathSensors, Inc. to sponsor and exhibit at ExperienceFR 2020
Feb 13, 2020
FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning
Feb 06, 2020
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Feb 03, 2020
Theraderm® Clinical Skincare Repairs Skin, Generates Cell Growth For Rapid Wound-Healing + Wrinkle Reduction
Jan 30, 2020
Soligenix to Present at the 22nd Annual BIO CEO & Investor Conference
Jan 22, 2020
Proteostasis Therapeutics Announces Keystone Symposia Presentation of Organoid Study from More than 300 Adult CF Patients
Jan 20, 2020
ZyVersa Therapeutics Releases Video Demonstrating How Inflammasomes Stimulate and Perpetuate Inflammation, and How a Novel Inflammasome Inhibitor, IC 100, Has Potential to Control Chronic Damaging Inflammation Associated with Inflammatory Diseases
Jan 14, 2020
Soligenix - Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials
Jan 13, 2020
Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA
Dec 18, 2019
Soligenix to Receive $850,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Dec 17, 2019
Proteostasis Therapeutics Announces Positive Phase 2 Topline Results from Proprietary CFTR Modulator Combinations in F508del Homozygous Cystic Fibrosis Patients
Dec 12, 2019
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
Dec 11, 2019
Study Reveals Mechanisms that Help Pancreatic Cancer Cells Avert Starvation